A new trading day began on Tuesday, with Repare Therapeutics Inc (NASDAQ: RPTX) stock price up 14.17% from the previous day of trading, before settling in for the closing price of $1.20. RPTX’s price has ranged from $0.89 to $4.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1421.52% over the past five years. Meanwhile, its annual earnings per share averaged -5.25%. With a float of $30.51 million, this company’s outstanding shares have now reached $42.51 million.
Let’s look at the performance matrix of the company that is accounted for 129 employees. In terms of profitability, gross margin is 98.15%, operating margin of -174.4%, and the pretax margin is -155.19%.
Repare Therapeutics Inc (RPTX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Repare Therapeutics Inc is 28.24%, while institutional ownership is 42.87%. The most recent insider transaction that took place on Mar 12 ’25, was worth 4,099. In this transaction EVP, CHIEF MEDICAL OFFICER of this company sold 3,596 shares at a rate of $1.14, taking the stock ownership to the 227,813 shares. Before that another transaction happened on Mar 12 ’25, when Company’s EVP, CHIEF SCIENTIFIC OFFICER sold 5,611 for $1.14, making the entire transaction worth $6,397. This insider now owns 80,297 shares in total.
Repare Therapeutics Inc (RPTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.52% during the next five years compared to -21.89% drop over the previous five years of trading.
Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators
Here are Repare Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Repare Therapeutics Inc (RPTX)
Repare Therapeutics Inc (NASDAQ: RPTX) saw its 5-day average volume 1.01 million, a positive change from its year-to-date volume of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 78.83%. Additionally, its Average True Range was 0.10.
During the past 100 days, Repare Therapeutics Inc’s (RPTX) raw stochastic average was set at 15.10%, which indicates a significant decrease from 92.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.00% in the past 14 days, which was lower than the 149.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1309, while its 200-day Moving Average is $2.3979. Nevertheless, the first resistance level for the watch stands at $1.4533 in the near term. At $1.5367, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.6633. If the price goes on to break the first support level at $1.2433, it is likely to go to the next support level at $1.1167. Assuming the price breaks the second support level, the third support level stands at $1.0333.
Repare Therapeutics Inc (NASDAQ: RPTX) Key Stats
With a market capitalization of 58.24 million, the company has a total of 42,511K Shares Outstanding. Currently, annual sales are 53,480 K while annual income is -84,690 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,410 K.
